Catalyst Capital Advisors’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-416	Closed	-$8K	–	416
2019 Q2	$8K	Buy	+416	New	+$8K	﹤0.01%	326